LBTD (Lotus Bio-Technology Development) Notes Receivable: $0.00 Mil (As of Dec. 2017)


What is Lotus Bio-Technology Development Notes Receivable?

Lotus Bio-Technology Development LBTD -99.99% Notes Receivable is $0.00 Mil as of Dec. 2017.

Lotus Bio-Technology Development's Notes Receivable for the quarter that ended in Dec. 2017 was $0.00 Mil.

Lotus Bio-Technology Development Notes Receivable Related Terms

Lotus Bio-Technology Development Notes Receivable Historical Data

* Premium members only.

The historical data trend for Lotus Bio-Technology Development's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Bio-Technology Development Notes Receivable Chart

Lotus Bio-Technology Development Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Lotus Bio-Technology Development Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Lotus Bio-Technology Development Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Lotus Bio-Technology Development (LBTD) has a Notes Receivable of $0.00 Mil as of Dec. 2017. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Lotus Bio-Technology Development and its competitors.
Is Lotus Bio-Technology Development's Notes Receivable too high?
Lotus Bio-Technology Development's current Notes Receivable is $0.00 Mil.
How does Lotus Bio-Technology Development's Notes Receivable compare to SNES and CVAT?
Lotus Bio-Technology Development's Notes Receivable of $0.00 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for an Agriculture company?
A good Notes Receivable depends on the Agriculture industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Lotus Bio-Technology Development and its competitors. Lotus Bio-Technology Development's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Bio-Technology Development stock overvalued right now?
Lotus Bio-Technology Development (LBTD) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Lotus Bio-Technology Development (LBTD), the current Notes Receivable is $0.00 Mil as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lotus Bio-Technology Development Business Description

Address 108 2559 Parkview Lane, Port Coquitlam, BC, CAN, V3C6M1
Lotus Bio-Technology Development Corp is actively seeking out new opportunities in the Organic and Bio-technology space.